TD Waterhouse Canada’s Oncolytics Biotech ONCY Stock Holding History

TD Waterhouse Canada’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$597	Hold	662	–	–	﹤0.01%	2237
2026 Q1	$562	Buy	662 +262	+66%	+$261	﹤0.01%	2141
2025 Q4	$353	Hold	400	–	–	﹤0.01%	1920
2025 Q3	$562	Hold	400	–	–	﹤0.01%	1933
2025 Q2	$299	Hold	400	–	–	﹤0.01%	1872
2025 Q1	$209	Sell	400 -157	-28%	-$115	﹤0.01%	1841
2024 Q4	$507	Hold	557	–	–	﹤0.01%	1827
2024 Q3	$481	Sell	557 -105	-16%	-$103	﹤0.01%	1754
2024 Q2	$660	Buy	+662	New	+$721	﹤0.01%	1760
2024 Q1	–	Sell	-557	Closed	-$970	–	1894
2023 Q4	$970	Hold	557	–	–	﹤0.01%	1558
2023 Q3	$1.57K	Hold	557	–	–	﹤0.01%	1520
2023 Q2	$1.89K	Hold	557	–	–	﹤0.01%	1544
2023 Q1	$880	Buy	557 +157	+39%	+$246	﹤0.01%	1609
2022 Q4	$840	Hold	400	–	–	﹤0.01%	1574
2022 Q3	$680	Hold	400	–	–	﹤0.01%	1606
2022 Q2	$511	Hold	400	–	–	﹤0.01%	1667
2022 Q1	$796	Sell	400 -1,089	-73%	-$1.83K	﹤0.01%	1689
2021 Q4	$2.62K	Buy	+1,489	New	+$2.75K	﹤0.01%	1551

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

BPWM

Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TD Waterhouse Canada's ONCY Position: Q2 2026 in Review

TD Waterhouse Canada held its Oncolytics Biotech (ONCY) position steady in Q2 2026 at 662 shares worth $597. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

TD Waterhouse Canada first reported a position in ONCY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.62K in Q4 2021. 24 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

TD Waterhouse Canada held 662 shares of Oncolytics Biotech worth $597 as of Q2 2026.
TD Waterhouse Canada left its Oncolytics Biotech share count unchanged in Q2 2026.
Oncolytics Biotech made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2237 holding.
TD Waterhouse Canada first reported a position in Oncolytics Biotech in Q4 2021 and has held it in 18 quarters since.
TD Waterhouse Canada's Oncolytics Biotech position peaked at $2.62K in Q4 2021.
24 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.